Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2018-09-20 | buprenorphine | Camurus (Sweden) | opioid dependence | Positive opinion for the granting of a Market Authorisation in the EU |
2018-09-20 | cabozantinib | Exelixis (USA - CA) Ipsen (France) | hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib | Positive opinion for the granting of a Market Authorisation in the EU |
2018-09-10 | orilanolimab | Syntimmune (USA - MA) | pemphigus | Granting of the orphan status in the US |
2018-09-27 | relacorilant | Corcept Therapeutics (USA - CA) | pancreatic cancer | Granting of the orphan status in the US |
2018-09-24 | duvelisib (IPI-145) | Verastem (USA - MA) |
|
Granting of a Market Authorisation in the US |
2018-10-02 | sarecycline) | Allergan (Ireland) Paratek Pharmaceuticals (USA - MA) | moderate to severe acne | Granting of a Market Authorisation in the US |
2017-09-21 | omadacycline | Paratek Pharmaceuticals (USA - MA) | uncomplicated urinary tract infections (uUTI) | Granting of a Fast Track status |
2018-08-08 | omadacycline | Paratek Pharmaceuticals (USA - MA) | acute bacterial skin and skin structure infections (ABSSSI) (17-1) and community-acquired bacterial pneumonia (CABP) (14-4) | Positive opinion for the granting of a Market Authorisation in the US |
2017-06-15 | tazemetostat | Epizyme (USA - MA) | soft tissue sarcoma (STS). | Granting of the orphan status in the US |
2018-10-03 | lenabasum | Corbus Pharmaceuticals (USA - MA) | Granting of a patent | |
2018-09-05 | LOXO-292 | Loxo Oncology (USA - CT) |
|
Granting of the Breakthrough Therapy status |
2018-08-27 | adenovirus associated viral vector serotype 8 containing the human Cyclic Nucleotide Gated Channel Alpha 3 subunit (CNGA3) gene | MeiraGTx (USA - NY) | achromatopsia caused by mutations in the CNGA3 gene | Granting of the orphan status in the US |
2018-02-01 | aadenovirus associated viral vector serotype 8 containing the human AIPL1 gene | MeiraGTx (USA - NY) |
|
Granting of the orphan status in the US |
2013-05-03 | replication-deficient recombinant serotype 2 adeno-associated viral vector containing hAQP1 cDNA | MeiraGTx (USA - NY) |
|
Granting of the orphan status in the US |
2015-06-04 | 3D laser assisted bioprinting technology | Poietis (France) | Granting of a patent | |
2017-05-12 | single-cell laser assisted bioprinting platform for the production of 3D tissue models | Poietis (France) | Product launch | |
2018-01-23 | bioprinted skin model | Poietis (France) | Product launch | |
2017-10-24 | Medivir (Sweden) | osteoarthritis | Granting of a Fast Track status | |
2018-02-15 | siplizumab | ITB-Med (Sweden) | prevention of solid organ transplant rejection | Granting of the orphan status in the US |
2018-10-16 | talazoparib (BMN 673) | Pfizer (USA - NY) |
|
Granting of a Market Authorisation in the US |
© 2024 Biopharmanalyses - Powered by Samacom+